Could earlier aspirin after stroke save more brains?

NCT ID NCT07563673

Not yet recruiting Disease control Sponsor: Beijing Chao Yang Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving a low-dose aspirin just 2 hours after clot-busting treatment for stroke is better than waiting the standard 24 hours. About 210 adults aged 18-65 who had a stroke will be randomly assigned to get aspirin early or at the usual time. The goal is to see if early aspirin leads to better recovery and fewer complications like re-clogged arteries.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aspirin (low-dose, 100 mg)
What this could lead to: If successful, this could change guidelines to start aspirin earlier after clot-busting treatment, potentially reducing the risk of re-clogged arteries and improving recovery for stroke patients.
What could go wrong: This is a small, early-phase trial with only 210 participants, so results may not apply to all stroke patients. Giving aspirin earlier also raises a small risk of bleeding in the brain, which the study is carefully monitoring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral infarction ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL INFARCTION THROMBOLYSIS

Contacts and locations

Locations

Beijng Chao-Yang Hospital, Capital Medical University

Beijing, Beijing Municipality, 100020, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.